iCAD, Inc. engages in the provision of cancer detection and therapy solutions in the United States. It operates through two segments, Detection and Therapy. The company provides ProFound AI for digital breast tomosynthesis and 2D mammography; PowerLook, a density assessment solution; and ProFound Risk, a breast cancer risk analysis. The company was formerly known as Howtek, Inc. and changed its name to iCAD, Inc. in June 2002. iCAD, Inc. was incorporated in 1984 and is headquartered in Nashua, New Hampshire.
| 1.28 | |
| 1.3 | |
| - | |
| 1.33 | |
| 1.26 | |
| 1.18-2.95 | |
| 35 033 K | |
| 26 540 K | |
| 17 938 K | |
| -0.05 | |
| 1.499 |
No long-term obligations. The minimum period is one month only. No wait. You get an API key with instructions in a few seconds right after subscription.
It’s certainly a very good time to be in the AI business. After all, the technology has been getting huge amounts of positive publicity since December 2022, and it’s being viewed as a powerful, he...
iCAD, Inc. Mr. Doyle offers extensive experience in AI enabled healthcare platforms and global business strategy. NASHUA, N.H., Jan. 30, 2024 (GLOBE NEWSWIRE) -- iCAD, Inc. (NASDAQ: ICAD), a global ...
Our 24/7 support would be happy to assist you via chat or email:
support@eodhistoricaldata.comVisit also:
